Drug Shortage Report for CADUET

Last updated on 2024-04-16 History
Report ID 187510
Drug Identification Number 02273314
Brand name CADUET
Common or Proper name CADUET
Company Name BGP PHARMA ULC
Market Status MARKETED
Active Ingredient(s) ATORVASTATIN AMLODIPINE
Strength(s) 80MG 10MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 90
ATC code C10BX
ATC description LIPID MODIFYING AGENTS, COMBINATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2023-05-31
Actual start date 2023-06-06
Estimated end date 2024-07-09
Actual end date
Shortage status Actual shortage
Updated date 2024-04-16
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v32 2024-04-16 French Compare
v31 2024-04-16 English Compare
v30 2024-02-28 French Compare
v29 2024-02-28 English Compare
v28 2024-01-30 French Compare
v27 2024-01-30 English Compare
v26 2024-01-10 French Compare
v25 2024-01-10 English Compare
v24 2023-12-12 French Compare
v23 2023-12-12 English Compare
v22 2023-10-30 French Compare
v21 2023-10-30 English Compare
v20 2023-10-11 French Compare
v19 2023-10-11 English Compare
v18 2023-09-20 French Compare
v17 2023-09-20 English Compare
v16 2023-08-16 French Compare
v15 2023-08-16 English Compare
v14 2023-06-27 French Compare
v13 2023-06-27 English Compare

Showing 1 to 20 of 32